Mmb. Kay et al., MOLECULAR-BASIS OF HUMAN BAND-3 MUTATION ASSOCIATED WITH INCREASED ANION TRANSPORT, Experimental and clinical immunogenetics, 11(4), 1994, pp. 209-221
Band 3, the anion transporter, is a ubiquitous protein. It is present
in brain and all other tissues. Not only is band 3 present in cell mem
branes, but also in nuclear, Golgi, and mitochondrion membranes. Band
3 is involved in respiration, acid-base balance, and is the major stru
ctural protein linking the plasma membrane to the cytoskeleton. Thus,
alterations/mutations in the transport segment of the band-3 molecule
might be expected to be of major importance. We discovered and sequenc
ed a mutation of band 3, high-transport band 3 (HTbd3), that exhibits
anion transport that is 2-3 times above normal. Anion transport studie
s of the family members revealed that red cells from the proposita, on
e of two siblings, and both parents had abnormally increased anion tra
nsport (increased V-max). We used synthetic peptides of band 3 to help
localize the change along the band-3 molecule. Results suggest that h
igh-transport band 3 is altered in or near residue 869-883. This place
s the alteration toward the carboxyl terminal of band 3, cDNA sequenci
ng demonstrated that the mutation was a proline to leucine at residue
868. A peptide was synthesized corresponding to residues 853-870 for t
esting in the anion transport inhibition assay. This peptide significa
ntly inhibited anion transport (p less than or equal to 0.001) indicat
ing that it is an anion transport/binding region of band 3. Thus, DNA
technology confirms the validity of the anion transport inhibition ass
ay for localizing transport regions. Glucose transport is decreased in
affected individuals. The HTbd3 mutation appears benign as determined
by the red cell aging panel. IgG binding, creatinine, and glyceraldeh
yde-3-phosphate dehydrogenase are normal. Our studies indicate that th
e most rapid and sensitive techniques for detecting band-3 alterations
are polyacrylamide gel electrophoresis, IgG binding, and anion transp
ort studies. This is the only mutation of band 3 discovered to date th
at affects the transmembrane, anion transport region of band 3.